Christine Ring - 19 Jan 2022 Form 4 Insider Report for Nurix Therapeutics, Inc. (NRIX)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NRIX	Employee Stock Option (right to buy)	Award	$0	+69,262		$0.000000	69,262	19 Jan 2022	Common Stock	69,262	$19.49	Direct	F1
transaction	NRIX	Restricted Stock Units	Award	$0	+30,785		$0.000000	30,785	19 Jan 2022	Common Stock	30,785	$0.000000	Direct	F2, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The stock option vests as to 1/48 of the total shares monthly beginning February 19, 2022 until the option is fully vested on January 19, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
F2	Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
F3	The RSUs will vest in substantially equal increments quarterly over four years, with the first quarterly increment vesting on April 30, 2022, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's Common Stock will be delivered to the Reporting Person following vesting.
F4	RSUs do not expire; they either vest or are canceled prior to the vest date.